{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:52:27Z","timestamp":1792266747830,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06697-0","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:34:54Z","timestamp":1761298494000},"page":"5975-5994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BLNK as an important prognostic indicator for survival in pediatric classic hodgkin lymphoma patients: a single-center retrospective study"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3794-1106","authenticated-orcid":false,"given":"Yiwei","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3291-322X","authenticated-orcid":false,"given":"Yuanyuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6399-399X","authenticated-orcid":false,"given":"Xiuli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7102-7946","authenticated-orcid":false,"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5787-5444","authenticated-orcid":false,"given":"Wenting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6566-2638","authenticated-orcid":false,"given":"Yuqiao","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2126-9453","authenticated-orcid":false,"given":"Xiaofei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2491-6246","authenticated-orcid":false,"given":"Lian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"6697_CR1","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/s0140-6736(20)32207-8","volume":"398","author":"P Brice","year":"2021","unstructured":"Brice P, De Kerviler E, Friedberg JW (2021) Classical hodgkin lymphoma. Lancet 398:1518\u20131527. https:\/\/doi.org\/10.1016\/s0140-6736(20)32207-8","journal-title":"Lancet"},{"issue":"1","key":"6697_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0189-6","volume":"6","author":"JM Connors","year":"2020","unstructured":"Connors JM, Cozen W, Steidl C, Carbone A, Hoppe RT, Flechtner HH, Bartlett NL (2020) Hodgkin lymphoma. Nat Rev Dis Primers 6(1):61. https:\/\/doi.org\/10.1038\/s41572-020-0189-6","journal-title":"Nat Rev Dis Primers"},{"key":"6697_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A (2014) Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64:83\u2013103. https:\/\/doi.org\/10.3322\/caac.21219","journal-title":"CA Cancer J Clin"},{"key":"6697_CR4","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/ajh.26717","volume":"97","author":"SM Ansell","year":"2022","unstructured":"Ansell SM (2022) Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol 97:1478\u20131488. https:\/\/doi.org\/10.1002\/ajh.26717","journal-title":"Am J Hematol"},{"key":"6697_CR5","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1182\/blood.2022015575","volume":"141","author":"BJ Stewart","year":"2023","unstructured":"Stewart BJ, Fergie M, Young M (2023) Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma. Blood 141:2343\u20132358. https:\/\/doi.org\/10.1182\/blood.2022015575","journal-title":"Blood"},{"key":"6697_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1200\/op.21.00890","volume":"18","author":"P Torka","year":"2022","unstructured":"Torka P, Przespolewski E, Evens AM (2022) Treatment strategies for advanced classical Hodgkin lymphoma in the times of Dacarbazine shortage. JCO Oncol Pract 18:491\u2013497. https:\/\/doi.org\/10.1200\/op.21.00890","journal-title":"JCO Oncol Pract"},{"key":"6697_CR7","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1182\/blood.2022019254","volume":"141","author":"RC Lynch","year":"2023","unstructured":"Lynch RC, Ujjani CS, Poh C et al (2023) Concurrent pembrolizumab with AVD for untreated classical hodgkin lymphoma. Blood 141:2576\u20132586. https:\/\/doi.org\/10.1182\/blood.2022019254","journal-title":"Blood"},{"key":"6697_CR8","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","volume":"35","author":"MA Weniger","year":"2021","unstructured":"Weniger MA, K\u00fcppers R (2021) Molecular biology of Hodgkin lymphoma. Leukemia 35:968\u2013981. https:\/\/doi.org\/10.1038\/s41375-021-01204-6","journal-title":"Leukemia"},{"key":"6697_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105419","volume":"25","author":"S Pathmanathan","year":"2022","unstructured":"Pathmanathan S, Yao Z, Coelho P et al (2022) B cell linker protein (BLNK) is a regulator of Met receptor signaling and trafficking in non-small cell lung cancer. iScience 25:105419. https:\/\/doi.org\/10.1016\/j.isci.2022.105419","journal-title":"iScience"},{"key":"6697_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2020.107662","volume":"212","author":"L Soini","year":"2020","unstructured":"Soini L, Leysen S, Davis J, Ottmann C (2020) A biophysical and structural analysis of the interaction of BLNK with 14-3-3 proteins. J Struct Biol 212:107662. https:\/\/doi.org\/10.1016\/j.jsb.2020.107662","journal-title":"J Struct Biol"},{"key":"6697_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1158\/0008-5472.can-07-3169","volume":"68","author":"N Gupta","year":"2008","unstructured":"Gupta N, Delrow J, Drawid A, Sengupta AM, Fan G, G\u00e9linas C (2008) Repression of B-cell linker (BLNK) and B-cell adaptor for phosphoinositide 3-kinase (BCAP) is important for lymphocyte transformation by rel proteins. Cancer Res 68:808\u2013814. https:\/\/doi.org\/10.1158\/0008-5472.can-07-3169","journal-title":"Cancer Res"},{"key":"6697_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/sj.leu.2403702","volume":"19","author":"T Marafioti","year":"2005","unstructured":"Marafioti T, Pozzobon M, Hansmann ML (2005) Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma. Leukemia 19:856\u2013861. https:\/\/doi.org\/10.1038\/sj.leu.2403702","journal-title":"Leukemia"},{"key":"6697_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2003-05-1487","volume":"103","author":"T Marafioti","year":"2004","unstructured":"Marafioti T, Pozzobon M, Hansmann ML, Delsol G, Pileri SA, Mason DY (2004) Expression of intracellular signaling molecules in classical and lymphocyte predominance hodgkin disease. Blood 103:188\u2013193. https:\/\/doi.org\/10.1182\/blood-2003-05-1487","journal-title":"Blood"},{"key":"6697_CR14","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.3892\/mmr.2017.7158","volume":"16","author":"Z Kuang","year":"2017","unstructured":"Kuang Z, Guo L, Li X (2017) Identification of key genes and pathways associated with classical hodgkin lymphoma by bioinformatics analysis. Mol Med Rep 16:4685\u20134693. https:\/\/doi.org\/10.3892\/mmr.2017.7158","journal-title":"Mol Med Rep"},{"key":"6697_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108630","volume":"27","author":"C Jiang","year":"2024","unstructured":"Jiang C, Huang LY, Zhou JH (2024) Epstein-barr virus-based prognostic model in nodular sclerosis classic hodgkin lymphoma. iScience 27:108630. https:\/\/doi.org\/10.1016\/j.isci.2023.108630","journal-title":"iScience"},{"key":"6697_CR16","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1182\/blood.v96.4.1280","volume":"96","author":"A Josting","year":"2000","unstructured":"Josting A, Rueffer U, Franklin J, Sieber M, Diehl V, Engert A (2000) Prognostic factors and treatment outcome in primary progressive hodgkin lymphoma: a report from the German hodgkin lymphoma study group. Blood 96:1280\u20131286. https:\/\/doi.org\/10.1182\/blood.v96.4.1280","journal-title":"Blood"},{"key":"6697_CR17","doi-asserted-by":"publisher","first-page":"668","DOI":"10.7499\/j.issn.1008-8830.2412144","volume":"27","author":"Y Lin","year":"2025","unstructured":"Lin Y, Pan LL, Le SH, Li J, Guo BY, Zhu Y, Weng KZ, Luo JH, Sun GY, Zheng YZ (2025) Clinical characteristics and survival analysis of pediatric hodgkin lymphoma: a multicenter study. Chin J Contemp Pediatr 27:668\u2013674. https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2412144","journal-title":"Chin J Contemp Pediatr"},{"key":"6697_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/1097-0142(19940101)73:1<85::aid-cncr2820730116>3.0.co;2-8","volume":"73","author":"H Yoshikawa","year":"1994","unstructured":"Yoshikawa H, Rettig WJ, Takaoka K, Alderman E, Rup B, Rosen V, Wozney JM, Lane JM, Huvos AG, Garin-Chesa P (1994) Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody. Cancer 73:85\u201391. https:\/\/doi.org\/10.1002\/1097-0142(19940101)73:1%3C85::aid-cncr2820730116%3E3.0.co;2-8","journal-title":"Cancer"},{"key":"6697_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jcms.2006.02.004","volume":"34","author":"LK Cheung","year":"2006","unstructured":"Cheung LK, Zheng LW, Ma L (2006) Effect of distraction rates on expression of bone morphogenetic proteins in rabbit mandibular distraction osteogenesis. Journal of Cranio-Maxillofacial Surgery 34:263\u2013269. https:\/\/doi.org\/10.1016\/j.jcms.2006.02.004","journal-title":"Journal of Cranio-Maxillofacial Surgery"},{"key":"6697_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-014-0221-9","volume":"9","author":"N Fedchenko","year":"2014","unstructured":"Fedchenko N, Reifenrath J (2014) Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue \u2013 a review. Diagn Pathol 9:221. https:\/\/doi.org\/10.1186\/s13000-014-0221-9","journal-title":"Diagn Pathol"},{"key":"6697_CR21","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1002\/1097-0142(20001215)89:12<2637::aid-cncr17>3.0.co;2-b","volume":"89","author":"RA Soslow","year":"2000","unstructured":"Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, Koki AT (2000) COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 89:2637\u20132645. https:\/\/doi.org\/10.1002\/1097-0142(20001215)89:12%3C2637::aid-cncr17%3E3.0.co;2-b","journal-title":"Cancer"},{"key":"6697_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.152821","volume":"216","author":"JH Lee","year":"2020","unstructured":"Lee JH, Lee JH, Ahn BK, Paik SS, Lee KH (2020) Prognostic value of B-cell linker protein in colorectal cancer. Pathol Res Pract 216:152821. https:\/\/doi.org\/10.1016\/j.prp.2020.152821","journal-title":"Pathol Res Pract"},{"key":"6697_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05117-9","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Chipurupalli S, Jiang P, Tavasoli M, Yoo BH, McPhee M, Mazinani S, Francia G, Kerbel RS, Rosen KV (2022) ErbB2\/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth. Cell Death Dis 13:687. https:\/\/doi.org\/10.1038\/s41419-022-05117-9","journal-title":"Cell Death Dis"},{"key":"6697_CR24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1139\/gen-2020-0178","volume":"64","author":"S Zhang","year":"2021","unstructured":"Zhang S, Zheng Y, Zhang G, Lin P, Wang W (2021) Genomic DNA methylation analysis reveals that BLNK is a key potential gene in the regulation of autophagy-related thyroid cancer progression. Genome 64:801\u2013812. https:\/\/doi.org\/10.1139\/gen-2020-0178","journal-title":"Genome"},{"key":"6697_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115073","volume":"213","author":"C Rossi","year":"2024","unstructured":"Rossi C, Manson G, Marouf A et al (2024) Classic Hodgkin lymphoma: the LYSA pragmatic guidelines. Eur J Cancer 213:115073. https:\/\/doi.org\/10.1016\/j.ejca.2024.115073","journal-title":"Eur J Cancer"},{"key":"6697_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31027","volume":"71","author":"JE Flerlage","year":"2024","unstructured":"Flerlage JE, Waters-Banker C, Fanale M, Beckerman R, Castellino SM, Liu N (2024) A systematic literature review of clinical evidence and treatment burden in newly diagnosed high\u2010risk pediatric patients with classical hodgkin lymphoma. Pediatr Blood Cancer 71:e31027. https:\/\/doi.org\/10.1002\/pbc.31027","journal-title":"Pediatr Blood Cancer"},{"key":"6697_CR27","doi-asserted-by":"publisher","first-page":"e28230","DOI":"10.1002\/pbc.28230","volume":"67","author":"M Pizzi","year":"2020","unstructured":"Pizzi M, Tazzoli S, Carraro E, Chaviano F, Massano D, Lovisa F, Mussolin L, Todesco A, Biffi A, D\u2019Amore ES, Pillon M, Rugge M (2020) Histology of pediatric classic hodgkin lymphoma: from diagnosis to prognostic stratification. Pediatr Blood Cancer 67:e28230. https:\/\/doi.org\/10.1002\/pbc.28230","journal-title":"Pediatr Blood Cancer"},{"key":"6697_CR28","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/10428194.2018.1493732","volume":"60","author":"P Farruggia","year":"2018","unstructured":"Farruggia P, Puccio G, Locatelli F et al (2018) Classical pediatric hodgkin lymphoma in very young patients: the Italian experience. Leuk Lymphoma 60:696\u2013702. https:\/\/doi.org\/10.1080\/10428194.2018.1493732","journal-title":"Leuk Lymphoma"},{"key":"6697_CR29","doi-asserted-by":"publisher","first-page":"7672","DOI":"10.1002\/cam4.3408","volume":"9","author":"Z Tian","year":"2020","unstructured":"Tian Z, Tang J, Liao X, Yang Q, Wu Y, Wu G (2020) An immune-related prognostic signature for predicting breast cancer recurrence. Cancer Med 9:7672\u20137685. https:\/\/doi.org\/10.1002\/cam4.3408","journal-title":"Cancer Med"},{"key":"6697_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01277-w","volume":"24","author":"Q Zhao","year":"2024","unstructured":"Zhao Q, Li F, Li J, Xia Y, Wang J, Chen L (2024) An inflammatory response-related gene signature can predict the prognosis and impact the immune infiltration of multiple myeloma. Clin Exp Med 24:16. https:\/\/doi.org\/10.1007\/s10238-023-01277-w","journal-title":"Clin Exp Med"},{"issue":"2","key":"6697_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3760\/cma.j.cn321828-20240924-00333","volume":"45","author":"Chinese Society of Nuclear Medicine","year":"2025","unstructured":"Chinese Society of Nuclear Medicine (2025) Clinical application guidelines for PET\/CT and PET\/MR imaging in lymphoma (2025 Edition). Chin J Nucl Med Mol Imaging 45(2):94\u2013104. https:\/\/doi.org\/10.3760\/cma.j.cn321828-20240924-00333","journal-title":"Chin J Nucl Med Mol Imaging"},{"key":"6697_CR32","doi-asserted-by":"publisher","unstructured":"Jurwasi\u0107 V, Konjevi\u0107 G, Bani\u0107evi\u0107 B (2000) Different alterations in lactate dehydrogenase activity and profile of peripheral blood mononuclear cells in Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas. Eur J Haematol 64. https:\/\/doi.org\/10.1034\/j.1600-0609.2000.90117.x","DOI":"10.1034\/j.1600-0609.2000.90117.x"},{"key":"6697_CR33","doi-asserted-by":"publisher","unstructured":"Beltran B, Alva J, Morales D (2025) Prognostic factors for survival in 60 patients with classical hodgkin lymphoma from Peru.\u00a0Blood 118.\u00a0https:\/\/doi.org\/10.1182\/blood.v118.21.4863.4863.","DOI":"10.1182\/blood.v118.21.4863.4863"},{"key":"6697_CR34","doi-asserted-by":"publisher","unstructured":"Song R, Han X, Jie H (2023) Effects and mechanisms of Celastrol on the formation of neutrophil extracellular traps (NETs).\u00a0Ann Transl Med 11.\u00a0https:\/\/doi.org\/10.21037\/atm-22-5720.","DOI":"10.21037\/atm-22-5720"},{"key":"6697_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215503","author":"E Calabretta","year":"2019","unstructured":"Calabretta E, d\u2019Amore F, Carlo-Stella C (2019) Immune and inflammatory cells of the tumor microenvironment represent novel therapeutic targets in classical hodgkin lymphoma. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20215503","journal-title":"Int J Mol Sci"},{"key":"6697_CR36","doi-asserted-by":"crossref","unstructured":"Carreras E, Dufour C, Mohty M (2019) Classical Hodgkin\u2019s Lymphoma. The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies.","DOI":"10.1007\/978-3-030-02278-5"},{"key":"6697_CR37","doi-asserted-by":"publisher","unstructured":"Matsuki E, Younes A (2015) Lymphomagenesis in hodgkin lymphoma. Semin Cancer Biol 34. https:\/\/doi.org\/10.1016\/j.semcancer.2015.02.002","DOI":"10.1016\/j.semcancer.2015.02.002"},{"issue":"1","key":"6697_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/hematolrep15010012","volume":"15","author":"GF Tan","year":"2023","unstructured":"Tan GF, Goh S, Chang EWY (2023) Post-treatment neutrophil and lymphocyte counts predict progression-free survival following first-line chemotherapy in hodgkin\u2019s lymphoma. Hematol Rep 15(1):108\u2013118. https:\/\/doi.org\/10.3390\/hematolrep15010012","journal-title":"Hematol Rep"},{"key":"6697_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12747","author":"A Englund","year":"2016","unstructured":"Englund A, Molin D, Enblad G (2016) The role of tumour-infiltrating eosinophils, mast cells and macrophages in classical and nodular lymphocyte predominant Hodgkin lymphoma in children. Eur J Haematol. https:\/\/doi.org\/10.1111\/ejh.12747","journal-title":"Eur J Haematol"},{"issue":"7","key":"6697_CR40","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.cell.2023.02.032","volume":"186","author":"J Gungabeesoon","year":"2023","unstructured":"Gungabeesoon J, Gort-Freitas NA, Kiss M (2023) A neutrophil response linked to tumor control in immunotherapy. Cell 186(7):1448-1464e20. https:\/\/doi.org\/10.1016\/j.cell.2023.02.032","journal-title":"Cell"},{"issue":"7","key":"6697_CR41","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.cell.2023.03.007","volume":"186","author":"D Hirschhorn","year":"2023","unstructured":"Hirschhorn D, Budhu S, Kraehenbuehl L (2023) T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants. Cell 186(7):1432-1447e17. https:\/\/doi.org\/10.1016\/j.cell.2023.03.007","journal-title":"Cell"},{"key":"6697_CR42","doi-asserted-by":"publisher","unstructured":"Valsami S, Rontogianni D, Pappa V (2025) Immunohistochemical analysis of the expression of the B-Cell markers BCL-6, MUM1\/IRF4, CD79A and transcription factors BOB.1 and OCT.2 in classical hodgkin lymphoma.\u00a0Blood 106.\u00a0https:\/\/doi.org\/10.1182\/blood.v106.11.974.974.","DOI":"10.1182\/blood.v106.11.974.974"},{"key":"6697_CR43","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1309\/98klhrdam5cmdhe2","volume":"125","author":"ED Hsi","year":"2006","unstructured":"Hsi ED, Sup SJ, Alemany C, Tso E, Skacel M, Elson P, Alonso MA, Pohlman B (2006) MAL is expressed in a subset of hodgkin lymphoma and identifies a population of patients with poor prognosis. Am J Clin Pathol 125:776\u2013782. https:\/\/doi.org\/10.1309\/98klhrdam5cmdhe2","journal-title":"Am J Clin Pathol"},{"key":"6697_CR44","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/17474086.2020.1793666","volume":"13","author":"M Dalal","year":"2020","unstructured":"Dalal M, Gupta J, Price K, Zomas A, Miao H, Ashaye A (2020) Efficacy and safety of front-line treatments for advanced Hodgkin lymphoma: a systematic literature review. Expert Rev Hematol 13:907\u2013922. https:\/\/doi.org\/10.1080\/17474086.2020.1793666","journal-title":"Expert Rev Hematol"},{"key":"6697_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.694545","volume":"12","author":"F Pei","year":"2021","unstructured":"Pei F, Yu Y, Dong B, Guan H, Dong X, Zhao F (2021) Efficacies and toxicities of seven chemotherapy regimens for advanced hodgkin lymphoma. Front Pharmacol 12:694545. https:\/\/doi.org\/10.3389\/fphar.2021.694545","journal-title":"Front Pharmacol"},{"key":"6697_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3109\/0284186x.2014.948058","volume":"54","author":"A Englund","year":"2015","unstructured":"Englund A, Hopstadius C, Enblad G, Gustafsson G, Ljungman G (2015) Hodgkin lymphoma\u2013a survey of children and adolescents treated in Sweden 1985\u20132009. Acta Oncol 54:41\u201348. https:\/\/doi.org\/10.3109\/0284186x.2014.948058","journal-title":"Acta Oncol"},{"key":"6697_CR47","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/s41591-025-03668-w","volume":"31","author":"AW Chan","year":"2025","unstructured":"Chan AW, Boutron I, Hopewell S et al (2025) SPIRIT 2025 statement: updated guideline for protocols of randomized trials. Nat Med 31:1784\u20131792. https:\/\/doi.org\/10.1038\/s41591-025-03668-w","journal-title":"Nat Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06697-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06697-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06697-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T02:31:16Z","timestamp":1764729076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06697-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["6697"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06697-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6749066\/v1","asserted-by":"object"}]},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee of the Fourth Hospital of Hebei Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no ethical, legal, or financial conflicts related to this article. All the authors have read and approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publish"}},{"value":"Informed consent was obtained from all patients at the time of sample collection.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}